Lloyd Klickstein

Lloyd Klickstein, Chief Science Officer at resTORbio and a former Novartis and Brigham and Women's Hospital scientist, dives into the fascinating world of aging and how rapamycin could revolutionize longevity. He shares insights from his influential research on mTOR inhibition and its potential to enhance immune function, particularly in older adults. The discussion compares rapamycin’s effects to fasting and its implications for healthspan. With a look at innovative clinical applications, Klickstein highlights the significance of bridging basic science and medicine to tackle age-related health issues.